Integrase Inhibitors Global Market Report 2025

Name: Integrase Inhibitors Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Download Sample Buy Report

Global Integrase Inhibitors Market Report 2025

Integrase Inhibitors Global Market Report 2025 - By Drugs (Raltegravir, Dolutagravir, Elvitegravir, Bictegravir), By Route of Administration (Oral, Intravenous, Subcutaneous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Therapeutic Area (HIV Infection, HCV Infection, Other Viral Infections), By End User (Hospitals, Clinics, Research Institutes) - Market Size, Trends, And Global Forecast 2025-2034

Integrase Inhibitors Global Market Report 2025

Report Price : $4490.00 | Pages : 200 | Published : June 2025 | Delivery Time: 2-3 business days Info | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Integrase Inhibitors Global Market Report 2025

Proud Members Of

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Integrase Inhibitors Market?

Integrase inhibitors are a class of antiretroviral drugs that block the action of the human immunodeficiency virus (HIV) enzyme integrase, preventing the integration of viral DNA into the host cell's genome, thus inhibiting the replication of the virus and the progression of HIV infection. These inhibitors are primarily used in the treatment of HIV infection, often as part of combination therapy to reduce viral load and improve immune function.

The main drug types of integrase inhibitors include raltegravir, dolutegravir, elvitegravir, and bictegravir. Raltegravir is an antiretroviral medication used to treat HIV-1 infection by inhibiting the integrase enzyme, thereby preventing the virus from integrating its genetic material into the host cell's DNA. These drugs are administered through various routes, such as oral, intravenous, and subcutaneous, and are distributed through hospital pharmacies, retail pharmacies, and online pharmacies. Their therapeutic areas include HIV infection, HCV infection, and other viral infections. Key end users are hospitals, clinics, and research institutes.

Integrase Inhibitors Market Size and growth rate 2025 to 2029: Graph

What Is The Integrase Inhibitors Market Size 2025 And Growth Rate?

The integrase inhibitors market size has grown strongly in recent years. It will grow from $4.40 billion in 2024 to $4.71 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to rising HIV prevalence, rising global awareness and improvements, government initiatives and funding, a rise in HIV diagnosis and testing, and an aging HIV population.

What Is The Integrase Inhibitors Market Growth Forecast?

The integrase inhibitors market size is expected to see strong growth in the next few years. It will grow to $6.10 billion in 2029 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to an increase in HIV infections, increasing awareness about HIV treatment, expansion of preventive therapies, a rise in long-acting injectable treatment, and expanding insurance and reimbursement coverage. Major trends in the forecast period include the adoption of long-acting injectables, digital and telehealth integration, personalized HIV treatment, technological advancements, and the development of pediatric formulations.

Book your 30 minutes free consultation with our research experts

How Is The Integrase Inhibitors Market Segmented?

The integrase inhibitors market covered in this report is segmented –

1) By Drugs: Raltegravir, Dolutagravir, Elvitegravir, Bictegravir

2) By Route of Administration: Oral, Intravenous, Subcutaneous

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

4) By Therapeutic Area: HIV Infection, HCV Infection, Other Viral Infections

5) By End User: Hospitals, Clinics, Research Institutes

Subsegments:

1) By Raltegravir: Oral Tablet, Oral Suspension, Intravenous (IV) Injection

2) By Dolutegravir: Oral Tablet, Oral Suspension

3) By Elvitegravir: Oral Tablet, Oral Suspension

4) By Bictegravir: Oral Tablet

What Is Driving The Integrase Inhibitors Market? Rising HIV Infection Prevalence Propelling The Growth Of The Market Due To Increasing Need For Effective Treatments

Rising HIV infection prevalence is expected to propel the growth of the integrase inhibitors market going forward. HIV infection is a chronic viral condition caused by the human immunodeficiency virus, which attacks and weakens the immune system by destroying CD4+ T cells, increasing susceptibility to other infections and diseases. ?The growing prevalence of HIV infection is primarily driven by limited access to quality healthcare, which hampers prevention, testing, and treatment efforts, especially in marginalized communities. Integrase inhibitors are used in HIV treatment to effectively block the virus from integrating its genetic material into human DNA, reducing viral replication and helping to control the infection, which can contribute to lowering the overall prevalence of HIV. For instance, in October 2024, according to gov.uk, a UK-based public sector information website, in 2023, England recorded 6,008 new HIV diagnoses, reflecting a 51% increase compared to 3,975 cases in 2022. Therefore, rising HIV infection prevalence will drive the growth of the integrase inhibitors market.

Who Are The Major Players In The Global Integrase Inhibitors Market?

Major companies operating in the integrase inhibitors market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Bristol-Myers squibb Company, GlaxoSmithKline PLC, Gilead Sciences, Boehringer Ingelheim, Viatris Inc., Hetero Pharmaceuticals, ViiV Healthcare, Apotex, Shionogi Co. ltd., Aurobindo Pharma, Dr. Reddy's Laboratories, Cipla Limited, Lupin Limited, Torii Pharmaceutical Co. Ltd, Theratechnologies Inc., Adooq Bioscience, Aetos Pharma.

What Are The Key Trends Of The Global Integrase Inhibitors Market? The Role Of Unit Dose Packaging In Long-Term HIV Management

Major companies operating in the integrase inhibitors market are focusing on developing new packaging options, such as unit dose packaging, to enhance patient adherence, improve convenience, and ensure the safe and efficient delivery of antiretroviral treatments, particularly for long-term HIV management. Unit dose packaging is a pharmaceutical packaging system where each individual dose of medication is sealed separately, ensuring accurate dosage, convenience, and improved medication safety for patients. For instance, in February 2024, ViiV Healthcare, a UK-based pharmaceutical company specializing in the development of HIV treatments, launched Dovato (dolutegravir/lamivudine) in a blister pack format in the U.S. This product is approved as a complete regimen for the treatment of HIV-1 infection in adults who have no prior antiretroviral (ARV) treatment or for those who are virologically suppressed (HIV-1 RNA <50 copies/mL) on a stable ARV regimen with no history of treatment failure or known resistance to any component of Dovato.

What Are Latest Mergers And Acquisitions In The Integrase Inhibitors Market? Empowering HIV Patients Through Patent Pool Collaboration

In April 2024, ViiV Healthcare, a UK-based pharmaceutical company, partnered with Medicines Patent Pool (MPP) to expand access to dolutegravir (DTG)-based HIV medicines. This collaboration has enabled more than 1 billion packs of generic DTG medicines to reach 24 million people living with HIV in 128 low- and middle-income countries (LMICs), significantly improving treatment access and outcomes in these regions. The Medicines Patent Pool (MPP) is a Switzerland-based non-profit organization that facilitates access to life-saving medicines by negotiating patent licenses with manufacturers.

What Is The Regional Outlook For The Global Integrase Inhibitors Market?

North America was the largest region in the integrase inhibitors market in 2024. The regions covered in the integrase inhibitors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the integrase inhibitors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Integrase Inhibitors Market?

The integrase inhibitors market consists of sales of tablets, capsules, fixed-dose combination drugs, and injectable formulations. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Integrase Inhibitors Industry?

The integrase inhibitors market research report is one of a series of new reports from The Business Research Company that provides integrase inhibitors market statistics, including the integrase inhibitors industry global market size, regional shares, competitors with the integrase inhibitors market share, detailed integrase inhibitors market segments, market trends, and opportunities, and any further data you may need to thrive in the integrase inhibitors industry. This integrase inhibitors market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Integrase Inhibitors Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$4.71 billion
Revenue Forecast In 2034	$6.10 billion
Growth Rate	CAGR of 6.7% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The integrase inhibitors market covered in this report is segmented – 1) By Drugs: Raltegravir, Dolutagravir, Elvitegravir, Bictegravir 2) By Route of Administration: Oral, Intravenous, Subcutaneous 3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies 4) By Therapeutic Area: HIV Infection, HCV Infection, Other Viral Infections 5) By End User: Hospitals, Clinics, Research Institutes Subsegments: 1) By Raltegravir: Oral Tablet, Oral Suspension, Intravenous (IV) Injection 2) By Dolutegravir: Oral Tablet, Oral Suspension 3) By Elvitegravir: Oral Tablet, Oral Suspension 4) By Bictegravir: Oral Tablet
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Bristol-Myers squibb Company, GlaxoSmithKline PLC, Gilead Sciences, Boehringer Ingelheim, Viatris Inc., Hetero Pharmaceuticals, ViiV Healthcare, Apotex, Shionogi Co. ltd., Aurobindo Pharma, Dr. Reddy's Laboratories, Cipla Limited, Lupin Limited, Torii Pharmaceutical Co. Ltd, Theratechnologies Inc., Adooq Bioscience, Aetos Pharma.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Integrase Inhibitors Market Characteristics

3. Integrase Inhibitors Market Trends And Strategies

4. Integrase Inhibitors Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Integrase Inhibitors Growth Analysis And Strategic Analysis Framework

5.1. Global Integrase Inhibitors PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Integrase Inhibitors Market Growth Rate Analysis

5.4. Global Integrase Inhibitors Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Integrase Inhibitors Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Integrase Inhibitors Total Addressable Market (TAM)

6. Integrase Inhibitors Market Segmentation

6.1. Global Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Raltegravir

Dolutagravir

Elvitegravir

Bictegravir

6.2. Global Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral

Intravenous

Subcutaneous

6.3. Global Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

6.4. Global Integrase Inhibitors Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

HIV Infection

HCV Infection

Other Viral Infections

6.5. Global Integrase Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Clinics

Research Institutes

6.6. Global Integrase Inhibitors Market, Sub-Segmentation Of Raltegravir, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral Tablet

Oral Suspension

Intravenous (IV) Injection

6.7. Global Integrase Inhibitors Market, Sub-Segmentation Of Dolutegravir, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral Tablet

Oral Suspension

6.8. Global Integrase Inhibitors Market, Sub-Segmentation Of Elvitegravir, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral Tablet

Oral Suspension

6.9. Global Integrase Inhibitors Market, Sub-Segmentation Of Bictegravir, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral Tablet

7. Integrase Inhibitors Market Regional And Country Analysis

7.1. Global Integrase Inhibitors Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Integrase Inhibitors Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Integrase Inhibitors Market

8.1. Asia-Pacific Integrase Inhibitors Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Integrase Inhibitors Market

9.1. China Integrase Inhibitors Market Overview

9.2. China Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Integrase Inhibitors Market

10.1. India Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Integrase Inhibitors Market

11.1. Japan Integrase Inhibitors Market Overview

11.2. Japan Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Integrase Inhibitors Market

12.1. Australia Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Integrase Inhibitors Market

13.1. Indonesia Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Integrase Inhibitors Market

14.1. South Korea Integrase Inhibitors Market Overview

14.2. South Korea Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Integrase Inhibitors Market

15.1. Western Europe Integrase Inhibitors Market Overview

15.2. Western Europe Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Integrase Inhibitors Market

16.1. UK Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Integrase Inhibitors Market

17.1. Germany Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Integrase Inhibitors Market

18.1. France Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Integrase Inhibitors Market

19.1. Italy Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Integrase Inhibitors Market

20.1. Spain Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Integrase Inhibitors Market

21.1. Eastern Europe Integrase Inhibitors Market Overview

21.2. Eastern Europe Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Integrase Inhibitors Market

22.1. Russia Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Integrase Inhibitors Market

23.1. North America Integrase Inhibitors Market Overview

23.2. North America Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Integrase Inhibitors Market

24.1. USA Integrase Inhibitors Market Overview

24.2. USA Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Integrase Inhibitors Market

25.1. Canada Integrase Inhibitors Market Overview

25.2. Canada Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Integrase Inhibitors Market

26.1. South America Integrase Inhibitors Market Overview

26.2. South America Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Integrase Inhibitors Market

27.1. Brazil Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Integrase Inhibitors Market

28.1. Middle East Integrase Inhibitors Market Overview

28.2. Middle East Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Integrase Inhibitors Market

29.1. Africa Integrase Inhibitors Market Overview

29.2. Africa Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Integrase Inhibitors Market Competitive Landscape And Company Profiles

30.1. Integrase Inhibitors Market Competitive Landscape

30.2. Integrase Inhibitors Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Bristol-Myers squibb Company Overview, Products and Services, Strategy and Financial Analysis

30.2.5. GlaxoSmithKline PLC Overview, Products and Services, Strategy and Financial Analysis

31. Integrase Inhibitors Market Other Major And Innovative Companies

31.1. Gilead Sciences

31.2. Boehringer Ingelheim

31.3. Viatris Inc.

31.4. Hetero Pharmaceuticals

31.5. ViiV Healthcare

31.6. Apotex

31.7. Shionogi Co. ltd.

31.8. Aurobindo Pharma

31.9. Dr. Reddy's Laboratories

31.10. Cipla Limited

31.11. Lupin Limited

31.12. Torii Pharmaceutical Co. Ltd

31.13. Theratechnologies Inc.

31.14. Adooq Bioscience

31.15. Aetos Pharma

32. Global Integrase Inhibitors Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Integrase Inhibitors Market

34. Recent Developments In The Integrase Inhibitors Market

35. Integrase Inhibitors Market High Potential Countries, Segments and Strategies

35.1 Integrase Inhibitors Market In 2029 - Countries Offering Most New Opportunities

35.2 Integrase Inhibitors Market In 2029 - Segments Offering Most New Opportunities

35.3 Integrase Inhibitors Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Integrase Inhibitors Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Integrase Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Integrase Inhibitors Market, Sub-Segmentation Of Raltegravir, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Integrase Inhibitors Market, Sub-Segmentation Of Dolutegravir, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Integrase Inhibitors Market, Sub-Segmentation Of Elvitegravir, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Integrase Inhibitors Market, Sub-Segmentation Of Bictegravir, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Integrase Inhibitors Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Global Integrase Inhibitors Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Asia-Pacific, Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: Asia-Pacific, Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: China, Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: China, Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: India, Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: India, Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Japan, Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Japan, Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Australia, Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Australia, Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Indonesia, Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: Indonesia, Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: South Korea, Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: South Korea, Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Western Europe, Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: Western Europe, Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: UK, Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: UK, Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Germany, Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: Germany, Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: France, Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: France, Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Italy, Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Italy, Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Spain, Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Spain, Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Eastern Europe, Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Eastern Europe, Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Russia, Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: Russia, Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: North America, Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: North America, Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: USA, Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: USA, Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: Canada, Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: Canada, Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: South America, Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: South America, Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Brazil, Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Brazil, Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Middle East, Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Middle East, Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Africa, Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: Africa, Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 80: Pfizer Inc. Financial Performance

Table 81: Johnson & Johnson Financial Performance

Table 82: Merck & Co. Inc. Financial Performance

Table 83: Bristol-Myers squibb Company Financial Performance

Table 84: GlaxoSmithKline PLC Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Integrase Inhibitors Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Integrase Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Integrase Inhibitors Market, Sub-Segmentation Of Raltegravir, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Integrase Inhibitors Market, Sub-Segmentation Of Dolutegravir, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Integrase Inhibitors Market, Sub-Segmentation Of Elvitegravir, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Integrase Inhibitors Market, Sub-Segmentation Of Bictegravir, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Integrase Inhibitors Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Global Integrase Inhibitors Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Asia-Pacific, Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: Asia-Pacific, Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: China, Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: China, Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: India, Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: India, Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Japan, Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Japan, Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Australia, Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Australia, Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Indonesia, Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: Indonesia, Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: South Korea, Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: South Korea, Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Western Europe, Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: Western Europe, Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: UK, Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: UK, Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Germany, Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: Germany, Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: France, Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: France, Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Italy, Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Italy, Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Spain, Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Spain, Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Eastern Europe, Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Eastern Europe, Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Russia, Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: Russia, Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: North America, Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: North America, Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: USA, Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: USA, Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: Canada, Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: Canada, Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: South America, Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: South America, Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Brazil, Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Brazil, Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Middle East, Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Middle East, Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Integrase Inhibitors Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Africa, Integrase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: Africa, Integrase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 80: Pfizer Inc. Financial Performance

Figure 81: Johnson & Johnson Financial Performance

Figure 82: Merck & Co. Inc. Financial Performance

Figure 83: Bristol-Myers squibb Company Financial Performance

Figure 84: GlaxoSmithKline PLC Financial Performance

Exploring Key Insights of the 3D Bioprinting Market: Growth Prospects, Emerging Trends, and Opportunities

Exploring Key Insights of the AI-based Surgical Robots Market: Growth Prospects, Emerging Trends, and Opportunities

Analyzing the Future of Arrhythmia Monitoring Devices Market Dynamics 2025-2034: Growth Rate, Trends, and Major Opportunities

Unlocking the Future of the Autoinjectors Market: Growth Rate, Key Trends, and Opportunities for 2025-2034

Top Growth Trends in the Bifurcation Lesions Market: Key Insights and Opportunities for 2025-2034

How is the Bioprocess Containers Market Poised for Growth: Trends and Opportunities Through 2034

How is the Blood Collection Devices Market Poised for Growth: Trends and Opportunities Through 2034

Growth Opportunities and Trends in the Blood Culture Tests Market: Key Insights for 2025-2034

HER2 Inhibitors Global Market Report 2025 – By Treatment (Monotherapy, Combination Therapy), By Application (Squamous Cell Carcinoma, Adenocarcinoma, Large Cell Carcinoma, Breast Cancer, Other Applications), By End User (Hospitals, Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Checkpoint Inhibitors Global Market Report 2025 – By Drug (PD-1 Inhibitors, PD-L1 Inhibitors, CTLA-4, Chimeric Antigen Receptor T-cell, Other Drugs), By Application (Lung Cancer, Renal Cancer, Blood Cancer, Bladder Cancer, Melanoma, Other Applications), By End-Users (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Protein Inhibitors Global Market Report 2025 – By Product (Protein Kinase Inhibitors, Monoclonal Antibody, Other Products), By Application (Oncology, Inflammatory Diseases, Other Applications), By Distribution Channel (Hospital Pharmacies, Independent Pharmacies, Online Pharmacies ) – Market Size, Trends, And Global Forecast 2025-2034

View Report

TNF Alpha Inhibitors Global Market Report 2025 – By Drug (Remicade (Infliximab), Enbrel (Etanercept), Humira (Adalimumab), Cimzia (Certolizumab Pegol), Simponi (Golimumab)), By Route Of Administration (Oral, Subcutaneous, Intravenous, Other Route Of Administration), By Disease Type (Inflammatory Bowel Disease, Psoriatic Arthritis, Ulcerative Colitis (UC), Rheumatoid Arthritis, Ankylosing Spondylitis, Other Disease Types) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Interleukin Inhibitors Global Market Report 2025 – By Type (IL-17, IL-23, IL-1, IL-5, IL-6, Other Types), By Application (Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis, Asthma, Inflammatory Bowel Disease, Other Applications), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2025-2034

View Report

ACE Inhibitors Global Market Report 2025 – By Type (Sulfhydryl-containing Agents, Dicarboxylate-containing Agents, Phosphonate-containing Agents), By Drug (Ramipril, Enalapril, Benazepril, Fosinopril, Captopril, Moexipril, Other Drugs), By Dosage Form (Oral Tablets, Oral Solutions), By Application (Heart Failure, Chronic Kidney Disease, Hypertension, Diabetes, Heart Attack, Other Applications), By End-Users (Hospitals, Online Drug Stores, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

PD-1 and PDL1 Inhibitors/ Immune Checkpoint Inhibitors Global Market Report 2025 – By Product (Nivolumab, Pembrolizumab, Atezolizumab, Avelumab, Durvalumab), By Distribution Channel (Hospital pharmacies, Retail pharmacies, Online pharmacies), By Application (Lung Cancer, Bladder Cancer, Melanoma, Hodgkin Lymphoma, Colorectal Cancer, Other Applications), By End-Users (Hospitals, Specialty Clinics, Academic and Research Institutions) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Proton Pump Inhibitors Global Market Report 2025 – By Type (Pantoprazole, Omeprazole, Lansoprazole, Esomeprazole, Rabeprazole, Dexlansoprazole, Other Types), By Disease Allocation (Ulcers, Gastroesophageal Reflux Disease, Other Disease Indications), By Application (Hospitals, Clinic, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Integrase Inhibitors market?

How will the Integrase Inhibitors market drivers and restraints affect the market dynamics? What forces will shape the Integrase Inhibitors industry going forward?

The Integrase Inhibitors market major growth driver - Rising HIV Infection Prevalence Propelling The Growth Of The Market Due To Increasing Need For Effective Treatments. For further insights on the Integrase Inhibitors market, request a sample here

What is the forecast market size or the forecast market value of the Integrase Inhibitors market?

The Integrase Inhibitors market size has grown strongly in recent years. The integrase inhibitors market size has grown strongly in recent years. It will grow from $4.40 billion in 2024 to $4.71 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to rising HIV prevalence, rising global awareness and improvements, government initiatives and funding, a rise in HIV diagnosis and testing, and an aging HIV population. The integrase inhibitors market size is expected to see strong growth in the next few years. It will grow to $6.10 billion in 2029 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to an increase in HIV infections, increasing awareness about HIV treatment, expansion of preventive therapies, a rise in long-acting injectable treatment, and expanding insurance and reimbursement coverage. Major trends in the forecast period include the adoption of long-acting injectables, digital and telehealth integration, personalized HIV treatment, technological advancements, and the development of pediatric formulations. For further insights on the Integrase Inhibitors market, request a sample here

How is the Integrase Inhibitors market segmented?

The integrase inhibitors market covered in this report is segmented –
1) By Drugs: Raltegravir, Dolutagravir, Elvitegravir, Bictegravir
2) By Route of Administration: Oral, Intravenous, Subcutaneous
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
4) By Therapeutic Area: HIV Infection, HCV Infection, Other Viral Infections
5) By End User: Hospitals, Clinics, Research Institutes
Subsegments:
1) By Raltegravir: Oral Tablet, Oral Suspension, Intravenous (IV) Injection
2) By Dolutegravir: Oral Tablet, Oral Suspension
3) By Elvitegravir: Oral Tablet, Oral Suspension
4) By Bictegravir: Oral Tablet For further insights on the Integrase Inhibitors market, request a sample here

Which region has the largest share of the Integrase Inhibitors market? What are the other regions covered in the report?

Who are the major players in the Integrase Inhibitors market?

What are the key trends in the Integrase Inhibitors market?

Major trends in the Integrase Inhibitors market include The Role Of Unit Dose Packaging In Long-Term HIV Management. For further insights on the Integrase Inhibitors market, request a sample here.

What are the major opportunities in the Integrase Inhibitors market? What are the strategies for the Integrase Inhibitors market?

For detailed insights on the major opportunities and strategies in the Integrase Inhibitors market, request a sample here.

How does the Integrase Inhibitors market relate to the overall economy and other similar markets?

For detailed insights on Integrase Inhibitors's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Integrase Inhibitors industry?

For detailed insights on the mergers and acquisitions in the Integrase Inhibitors industry, request a sample here.

What are the key dynamics influencing the Integrase Inhibitors market growth? SWOT analysis of the Integrase Inhibitors market.

For detailed insights on the key dynamics influencing the Integrase Inhibitors market growth and SWOT analysis of the Integrase Inhibitors industry, request a sample here.

Integrase Inhibitors Global Market Report 2025

Integrase Inhibitors Global Market Report 2025

Market Insights

Related Reports

What Is Covered Under Integrase Inhibitors Market?

What Is The Integrase Inhibitors Market Size 2025 And Growth Rate?

What Is The Integrase Inhibitors Market Growth Forecast?

How Is The Integrase Inhibitors Market Segmented?

What Is Driving The Integrase Inhibitors Market? Rising HIV Infection Prevalence Propelling The Growth Of The Market Due To Increasing Need For Effective Treatments

Who Are The Major Players In The Global Integrase Inhibitors Market?

What Are The Key Trends Of The Global Integrase Inhibitors Market? The Role Of Unit Dose Packaging In Long-Term HIV Management

What Are Latest Mergers And Acquisitions In The Integrase Inhibitors Market? Empowering HIV Patients Through Patent Pool Collaboration

What Is The Regional Outlook For The Global Integrase Inhibitors Market?

What Defines the Integrase Inhibitors Market?

How is Market Value Defined and Measured?

What is the Market Assessment and Strategic Outlook for the Integrase Inhibitors Industry?

Table Of Contents

List Of Tables

List Of Figures

Exploring Key Insights of the 3D Bioprinting Market: Growth Prospects, Emerging Trends, and Opportunities

Exploring Key Insights of the AI-based Surgical Robots Market: Growth Prospects, Emerging Trends, and Opportunities

Analyzing the Future of Arrhythmia Monitoring Devices Market Dynamics 2025-2034: Growth Rate, Trends, and Major Opportunities

Unlocking the Future of the Autoinjectors Market: Growth Rate, Key Trends, and Opportunities for 2025-2034

Top Growth Trends in the Bifurcation Lesions Market: Key Insights and Opportunities for 2025-2034

How is the Bioprocess Containers Market Poised for Growth: Trends and Opportunities Through 2034

How is the Blood Collection Devices Market Poised for Growth: Trends and Opportunities Through 2034

Growth Opportunities and Trends in the Blood Culture Tests Market: Key Insights for 2025-2034

Frequently Asked Questions